Close

InnerCap Technologies offers Combinaton Capsule Technology

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Revolutionizing Pharma Manufacturing with Biofermentation

Synthetic Chemistry and Integrated Biofermentation Transformational Pharmaceutical Manufacturing Combining biofermentation...

Thermo Fisher Partners with X-ELIO for Renewable Energy

Thermo Fisher Scientific has taken a significant step toward...

Cancer Diagnostics Market Outlook 2031: Growth Trends and Insights

The global cancer diagnostics market, valued at USD 163.7 billion...

Trends and Challenges to Face the Pharma Industry in 2024

The Clinical Research Organisation (CRO) sector is set for...

InnerCap Technologies, Inc., a drug delivery company, offers an advanced patent pending multi phased, multi compartmentalized capsular based delivery system. The system can be used to enhance the value and benefits of pharmaceutical and biopharmaceutical products. Utilizing two-piece hard shell capsules, the technology offers the industry solutions to problems affecting pharmaceutical companies, patients and healthcare providers. INNERCAP can fill a companies pipeline with a multitude of combination drug therapies.

The multi-phased, multi-compartmentalized capsular based drug delivery system will be licensed to enhance pharmaceutical and biopharmaceutical products. It is a very effective way to deliver multiple active chemical compounds in different physical phases with controlled release profiles.

 

This novel delivery system provides the pharmaceutical and biopharmaceutical industries with beneficial solutions to the industry’s highly publicized requirement to repackage and reformulate existing patented blockbuster drugs with expiring patents over the next five years. The delivery system is an exciting solution that will be used by forward looking companies to overcome issues such as life-cycle management, compliance, bioavailability, stability, difficult combination drug therapies, increase their pipeline of products, reduce generic competition, utilize more promising compounds and increase the difficulty in counterfeiting high value products.

 

Latest stories

Related stories

Revolutionizing Pharma Manufacturing with Biofermentation

Synthetic Chemistry and Integrated Biofermentation Transformational Pharmaceutical Manufacturing Combining biofermentation...

Thermo Fisher Partners with X-ELIO for Renewable Energy

Thermo Fisher Scientific has taken a significant step toward...

Cancer Diagnostics Market Outlook 2031: Growth Trends and Insights

The global cancer diagnostics market, valued at USD 163.7 billion...

Trends and Challenges to Face the Pharma Industry in 2024

The Clinical Research Organisation (CRO) sector is set for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back